Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B (OASIS)
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B: A Multicenter, Real-world Study
Sponsor: Beijing Ditan Hospital
This observational or N/A phase trial investigates Chronic Hepatitis b and is currently actively recruiting participants. Beijing Ditan Hospital leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
5 versions recorded-
Nov 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Nov 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2023 — Jul 2024 [monthly]
Recruiting
-
Jun 2021 — Feb 2023 [monthly]
Recruiting
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Ditan Hospital
- Beijing YouAn Hospital
- Chinese Foundation for Hepatitis Prevention and Control
- First Affiliated Hospital Xi'an Jiaotong University
- First Affiliated Hospital of Chongqing Medical University
- Henan Provincial People's Hospital
- Huashan Hospital
- Ningbo Beilun District Traditional Chinese Medicine Hospital
- Qingdao No.6 People's Hospital
- Taicang No.1 People's hospital
- The First Affiliated Hospital of Anhui Medical University
- The First Affiliated Hospital of Xiamen University
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- The Third People's Hospital of Taiyuan
- Third Affiliated Hospital, Sun Yat-Sen University
- Tianjing No.2 People's Hospital
- Wuxi No.5 People's Hospital
- Yunnan Provincial No.1 Hospital
For direct contact, visit the study record on ClinicalTrials.gov .